In a study presented as a poster (no. 164) at the 41st AMCLI Congress in Rimini in 2012, 83 Italian pediatric and adult patients with IBD were analyzed for the loss of tolerance to GP2 and ASCA reactivity. The gene discussed is GP2; the disease is inflammatory bowel disease.